IL185807A0 - Use of amino-substituted benzimidazoles - Google Patents

Use of amino-substituted benzimidazoles

Info

Publication number
IL185807A0
IL185807A0 IL185807A IL18580707A IL185807A0 IL 185807 A0 IL185807 A0 IL 185807A0 IL 185807 A IL185807 A IL 185807A IL 18580707 A IL18580707 A IL 18580707A IL 185807 A0 IL185807 A0 IL 185807A0
Authority
IL
Israel
Prior art keywords
amino
substituted benzimidazoles
compounds
substituted
benzimidazoles
Prior art date
Application number
IL185807A
Other languages
English (en)
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of IL185807A0 publication Critical patent/IL185807A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL185807A 2005-03-19 2007-09-06 Use of amino-substituted benzimidazoles IL185807A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005012875A DE102005012875B4 (de) 2005-03-19 2005-03-19 Verwendung von Amino substituierten 8-N-Benzimidazolen
PCT/EP2006/002057 WO2006099942A2 (de) 2005-03-19 2006-03-07 Verwendung von amino substituierten benzimidazolen

Publications (1)

Publication Number Publication Date
IL185807A0 true IL185807A0 (en) 2008-01-06

Family

ID=36933932

Family Applications (1)

Application Number Title Priority Date Filing Date
IL185807A IL185807A0 (en) 2005-03-19 2007-09-06 Use of amino-substituted benzimidazoles

Country Status (11)

Country Link
US (1) US8003668B2 (cg-RX-API-DMAC7.html)
EP (1) EP1863488B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008533066A (cg-RX-API-DMAC7.html)
AT (1) ATE458482T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006226639A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0608451A2 (cg-RX-API-DMAC7.html)
CA (1) CA2602236A1 (cg-RX-API-DMAC7.html)
DE (2) DE102005012875B4 (cg-RX-API-DMAC7.html)
IL (1) IL185807A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010836A (cg-RX-API-DMAC7.html)
WO (1) WO2006099942A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2121626A1 (en) * 2006-12-15 2009-11-25 Pfizer Products Inc. Benzimidazole derivatives
EA016888B1 (ru) 2007-06-29 2012-08-30 Пфайзер Инк. Производные бензимидазола
CN110698408B (zh) * 2012-02-17 2021-01-05 奇尼塔病毒性出血热有限责任公司 用于治疗沙粒病毒感染的抗病毒药物
WO2019079578A1 (en) * 2017-10-19 2019-04-25 Amgen Inc. BENZIMIDAZOLE DERIVATIVES AND USES THEREOF
HUE066335T2 (hu) 2018-10-05 2024-07-28 Annapurna Bio Inc Vegyületek és készítmények APJ receptor aktivitáshoz kapcsolódó állapotok kezelésére

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012613A1 (en) * 1995-10-05 1997-04-10 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6340681B1 (en) * 1999-07-16 2002-01-22 Pfizer Inc 2-benzimidazolylamine compounds as ORL-1-receptor agonists
AU2003240742A1 (en) * 2002-06-07 2003-12-22 Altana Pharma Ag 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors

Also Published As

Publication number Publication date
ATE458482T1 (de) 2010-03-15
EP1863488A2 (de) 2007-12-12
CA2602236A1 (en) 2006-09-28
BRPI0608451A2 (pt) 2009-12-29
US8003668B2 (en) 2011-08-23
WO2006099942A8 (de) 2006-11-09
DE502006006241D1 (de) 2010-04-08
US20080090870A1 (en) 2008-04-17
DE102005012875B4 (de) 2006-11-16
DE102005012875A1 (de) 2006-09-21
EP1863488B1 (de) 2010-02-24
JP2008533066A (ja) 2008-08-21
MX2007010836A (es) 2007-11-09
WO2006099942A2 (de) 2006-09-28
AU2006226639A1 (en) 2006-09-28
WO2006099942A3 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
IL185808A0 (en) Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
EA201170521A1 (ru) Новые соединения
WO2007127263A3 (en) Therapeutic uses of urolithins
AU2007221366A8 (en) Oxyntomodulin derivatives
MY153921A (en) Aminopyrazole derivatives
MX2009009416A (es) Derivados de bencimidazol y sus metodos de uso.
IN2012DN01233A (cg-RX-API-DMAC7.html)
WO2007115821A3 (en) Organic compounds
WO2009027346A3 (de) 17beta-hydroxysteroid-dehydrogenase-typ1-inhibitoren zur behandlung hormonabhängiger erkrankungen
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
WO2007144057A3 (en) Antimicrobial carbon
TW200630367A (en) Substituted adenines and the uses thereof
UA90698C2 (en) Triazole substituted aminobenzophenone compounds
TW200800969A (en) Compounds
IL185807A0 (en) Use of amino-substituted benzimidazoles
MX2010009575A (es) Derivados de pirazinonas como estimulantes de la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes.
WO2007130501A3 (en) Combination therapy for treatment of cancer
MX2010009577A (es) Derivados de piridopirazinona que estimulan la secrecion de insulina, metodos para obtenerlos y su uso en el tratamiento de la diabetes.
MX2010003071A (es) Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.
JO2773B1 (en) 2-oxo-alkyl-1-piprazine-2-1 derivatives, their preparation and therapeutic use.
MY155342A (en) Antitumoral compounds
UA103191C2 (ru) Производные арилпиразинона как стимуляторы секреции инсулина, способ их получения (варианты) и их применение для лечения диабета